Cancer Vaccine Succeeds in Late-Stage Melanoma Trial

A personalized mRNA cancer vaccine combined with existing treatment successfully slowed melanoma's return in a groundbreaking late-stage trial.

This first-of-its-kind success could open new doors for cancer patients worldwide.